Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy

DSpace Repository

Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy

Author: Hoffmann, E.; Toepell, A.; Peter, A.; Boeke, S.; De-Colle, C.; Steinle, M.; Niyazi, M.; Gani, C.
Tübinger Autor(en):
Steinle, Marc
Hoffmann, Elgin
Niyazi, Maximilian
Böke, Simon
Gani, Cihan
De-Colle, Chiara
Peter, Andreas
Toepell, Andreas
Published in: Strahlentherapie und Onkologie (2025), Bd. 201, H. 7, S. 679-686
Verlagsangabe: Heidelberg : Springer Heidelberg
Language: English
Full text: http://dx.doi.org/10.1007/s00066-024-02287-7
ISSN: 0179-7158
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)